GlassScriptPhysician profile
Casey Hargett
NPI 1487187068
$7,126.81
in general payments reported to CMS, 2019-2025
20 companies · $408 in 2025
The $408 reported for 2025 was more than what 82% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,552 · 2022: $1,848 · 2023: $1,954 · 2024: $1,365 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,727.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,942.40 | 2021-2024 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $1,847.20 | 2021-2025 | Biktarvy, Epclusa |
| Merck Sharp & Dohme LLC | $711.77 | 2021-2024 | Delstrigo, Pifeltro, Zerbaxa |
| Theratechnologies INC. | $597.04 | 2021-2024 | Egrifta, Trogarzo, Egrifta Sv |
| Insmed, INC. | $542.89 | 2021-2024 | Arikayce |
| Janssen Biotech, INC. | $396.83 | 2021-2023 | Symtuza |
| Astellas Pharma US INC | $309.41 | 2024-2025 | Veozah, Ambisome |
| Abbvie INC. | $278.02 | 2021-2025 | |
| Cumberland Pharmaceuticals, INC. | $135.93 | 2022 | |
| La Jolla Pharmaceutical Company | $80.43 | 2024 | Xerava, Xacduro |
| Exeltis, USA INC. | $64.54 | 2024-2025 | Slynd |
| Biogen, INC. | $51.93 | 2024 | Zurzuvae |
| Paratek Pharmaceuticals, INC. | $44.36 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Organon LLC | $24.20 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $16.39 | 2025 | Femlyv, Intrarosa |
| Amgen INC. | $15.94 | 2025 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $15.17 | 2025 | |
| Alexion Pharmaceuticals, INC. | $13.48 | 2022 | |
| Mayne Pharma Commercial LLC | $10.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Hargett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.